Advisory Board
Mark A. Wainberg
|
Mark A. Wainberg, PhD
mwainb1@po-box.mcgill.ca
McGill AIDS Centre
Jewish General Hospital
Montreal, Quebec
Positions
AScientific Director
Lady Davis Institute for Medical Research
Sir Mortimer B. Davis - Jewish General Hospital
Professor and Director
McGill AIDS Centre
McGill University
Professor
Department of Microbiology and Immunology
McGill University
Professor
Department of Medicine
McGill University
Staff Investigator
Head, Laboratory for Research on AIDS
Lady Davis Institute for Medical Research
Sir Mortimer B. Davis - Jewish General Hospital
Professor
Department of Pediatrics
McGill University
Date of Birth
April 21, 1945
Education
McGill University, Montreal (BS 1966)
Columbia University, New York (PhD 1972)
Areas of Specialty
Antiretroviral drug resistance, antiretroviral drug development
Recent Publications
Variant effects of non-native kissing-loop hairpin palindromes on HIV replication and HIV RNA dimerization: role of stem-loop B in HIV replication and HIV RNA dimerization.
Laughrea M; Shen N; Jette L; Wainberg MA. Biochemistry. 1999;38:226-34.
Enhanced impairment of chain elongation by inhibitors of HIV reverse transcriptase in cell-free reactions yielding longer DNA products.
Quan Y; Liang C; Inouye P; Wainberg MA. Nucleic Acids Res. 1998;26:5692-8.
Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependent.
Rae S; Raboud JM; Conway B; Reiss P; Vella S; Cooper D; Lange J; Harris M; Wainberg MA; Robinson P; Myers M; Hall D; Montaner JS. AIDS. 1998;12:2185-92.
HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons.
Bernard NF; Pederson K; Chung F; Ouellet L; Wainberg MA; Tsoukas CM. AIDS. 1998;12:2125-39.
Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications [editorial].
Friedman SR; Wainberg MA; Drucker E. AIDS. 1998;12:2089-93.
|
